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Abstract
The use of genetically-modified (GM) animals as research models continues to grow. The completion of the
mouse genome sequence, together with the high-throughput international effort to introduce mutations
across the mouse genome in the embryonic stem (ES) cells (www.knockoutmouse.org) facilitates an efficient
way to obtain mutated mouse strains as research models. The increasing number of available mutated mouse
strains and their combinations, together with the increasing complexity in the targeting approaches used,
reinforces the need for guidelines that will provide information about the mouse strains and the robust and
reliable methods used for their genotyping. This information, however, should be obtained with a method
causing minimal discomfort to the experimental animals. We have, therefore, compiled the present document
which summarizes the currently available methods for obtaining genotype information. It provides updated
guidelines concerning animal identification, DNA sampling and genotyping, and the information to be kept and
distributed for any mutated rodent strain.
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As a starting point, we have decided to collect informa-
tion on the genotyping practices applied in various
European countries, in order to identify common prob-
lems and pitfalls faced and to better direct our recom-
mendations. For this purpose, we have conducted a
survey focused on genotyping-related procedures used.
We have collected 158 responses from 25 countries (see
Supplementary information http://lan.sagepub.com/
content/suppl/2013/05/28/0023677212473918.DC1/
LAN473918_Supplementaryd_data.pdf), which will be
acknowledged in this report when appropriate. Only
three replies were received with regard to rats, which
seems to show that this species is still infrequently used
for genetically-modiﬁed (GM) models. From the
responses to this survey, we could conclude that the pro-
cedures are not harmonized among countries or even
among diﬀerent institutes within one country, and that
the common practice is not always in accordance with
the latest scientiﬁc ﬁndings.
Collection of samples for genotyping
Classical genotyping procedures for rodents rely on
polymerase chain reaction (PCR) and Southern blot
analyses of the DNA specimens obtained from tissue
samples of individual animals. This approach is also
supported by our survey, as shown in the Supplementary
information (please see http://lan.sagepub.com/content/
suppl/2013/05/28/0023677212473918.DC1/LAN473918_
Supplementaryd_data.pdf).
Traditionally, the most widely used methods for
obtaining the tissue material for genotyping are tail,
ear, or toe biopsies. Because collecting such biopsies
involves a given amount of discomfort for the animals,
alternative methods for DNA collection have been pro-
posed in order to reduce it. However, according to the
survey of the present study (Table 1) these ‘alternative’
methods are not widely used, possibly due to problems
related to accuracy, reproducibility, and practicability as
identiﬁed in our survey and on comparative tests carried
out by the members of this Working Group in their
facilities.
Guidelines for the reﬁnement and reduction of pro-
cedures involving GM rodents, also including recom-
mendations for DNA sampling, have been published
before by other Working Groups.1,2 One of the aims
of the present task, thus, was to re-evaluate those
guidelines in the light of new scientiﬁc evidence and
to provide up-to-date information about the most ade-
quate DNA sampling methods. These updated guide-
lines are general and will apply to the majority of
strains. The recommended techniques should, how-
ever, be adjusted in case of speciﬁc phenotypic con-
straints that should render them impossible,
inadequate, or more severe.
Identifying the animals to genotype
Animals have to be individually identiﬁed so that the
determined genotypes can be assigned to the correct
individuals. The FELASA Working Group on
Rodent Identiﬁcation has recently issued recommenda-
tions on this subject, which should be considered for
detailed information. Coincidently, some reliable iden-
tiﬁcation techniques provide a tissue sample as by-
product that can be used to extract DNA. Our primary
recommendation is, therefore, that whenever there is
the need to both identify an individual and collect a
DNA sample for genotyping, a method should be
chosen that meets both goals. This will avoid the use
of two invasive techniques and will minimize handling,
which is shown to be a major source of discomfort in
this process.3,4 The survey performed by our group (see
Table 1) showed that this rationale is not always fol-
lowed by researchers and, thus, intensive education is
needed in this regard.
Collecting DNA samples for genotyping
Overall, we recommend using the least invasive method
that provides an adequate DNA sample in terms of
quality and quantity to perform a robust genotyping
procedure as described in the previous section.
Whenever possible, this method should, at the same
time, provide highly reliable identiﬁcation.
Table 1. Methods used for sampling/genotyping and for
identification both in newborns up to P17, and from P18
onwards, presented as percentage of survey responders.
Method
Sampling/genotyping Identification
P0–P17 P18–adult P0–P17 P18–adult
Tail biopsy 42 79 NA NA
Ear notch/punch 5 43 8 64
Phalanx removal 12 4 20 6
Blood <1 13 NA NA
Hair 0 <1 NA NA
Faecal pellets 0 0 NA NA
Oral swab 0 0 NA NA
Ear tag NA NA 4 33
Tattoo/colour
marking
NA NA 15 6
Transponder NA NA 0 6
Isolation in a
single cage
NA NA 0 <1
UV light NA NA <1 0
No response 43 6 53 8
Total number of responders was 158. UV: ultraviolet, NA: not
applicable.
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In addition to the invasiveness of the process in itself,
the associated handling and restraining, which have
been shown to be a major stress factor, should be con-
sidered. Moreover, species, strain, age of the animal and
its phenotype must also be acknowledged. One should
also make every eﬀort to base judgement on scientiﬁc
data, and interpret concepts such as invasiveness, pain
and discomfort from the perspective of the animal,
avoiding excessive anthropomorphization.5,6
Those sampling techniques that are also identiﬁca-
tion methods are thoroughly described in the Report of
the Working Group on Rodent Identiﬁcation. In these
cases, our report will focus mainly on the aspects
related to the collection of samples for genotyping.
Ear biopsy. Ear biopsy is a widely used method where
a piece of tissue is removed from the mouse pinna. The
method provides both a DNA sample and a means of
identiﬁcation, based on the location of the biopsy. The
method seems not to induce major signs of discomfort3
and, because the ear is not very vascularized, bleeding is
also minimal if present at all. Surprisingly, only 43% of
the scientists in our survey reported using ear biopsy as
a DNA sampling method on animals older than 17 days
(Table 1). Moreover, 64% used this method for identi-
ﬁcation purposes upon genotyping, indicating that
around 20% of the scientists perform two invasive pro-
cedures where they could use just one.
There is a vast array of instruments that can be used
for the procedure, ranging from small scissors to
sophisticated ear punches with attached microtubes
for easy tissue collection. The 2mm version of the
punchers is recommended for yielding enough DNA
for PCR, while decreasing the risk of losing the identi-
ﬁcation mark by healing.
Before the ear is erect and when the pinna is still too
small, this method is not possible or not accurate for
identiﬁcation purposes. Although varying with strain
and individuals, the ear is usually suﬃciently developed
for this technique at around 14 days of age. After this
threshold, ear biopsy should be the method of choice
whenever there is a need for both permanent identiﬁca-
tion and collection of DNA for genotyping.
Tail biopsy. Tail biopsy consists of the amputation of a
small portion of the distal tail. Despite being reliable
and the most traditional tissue biopsy method for
obtaining DNA for genotyping (79% of the users in
our survey use the method in mice over 17 days of
age), this method does not provide any identiﬁcation,
thus requiring a concurrent procedure for this purpose.
For this reason alone, it should be discouraged as ﬁrst
option when permanent identiﬁcation is required unless
an adequate DNA sample cannot be obtained by a
more recommended technique.
If, however, this method is to be chosen, the follow-
ing points should be considered:
1. Recent studies have shown that taking the biopsy on
days 14 to 17 results in a less ossiﬁed sample which
can be signiﬁcantly shorter than what was recom-
mended in the previous guidelines;7,8
2. At this age, a 3mm long biopsy will provide enough
DNA for PCR. However, Southern blot analysis
might require longer (5 mm) biopsies;3,8,9
3. Most mice react to tail snip and this reaction
increases in intensity and number with age, probably
due to vertebral maturation;7,10
4. Some guidelines2,8 and institutions recommend the
use of analgesia or anaesthesia when a tail biopsy is
taken at the age of 21 days or older. However, results
of a recent study indicate that isoﬂurane anaesthesia
did not reduce acute behavioural responses to tail
biopsy in BALB/c and C57BL/6 mice.10
Furthermore, it remains controversial whether local
analgesia is eﬀective and whether general analgesia
or anaesthesia are advantageous in terms of global
welfare as these procedures are not without adverse
physiological impact.2,9,10
Because of the above, we recommend that tail biopsy
should be used only when the techniques that account
for both sampling and identiﬁcation do not provide a
tissue sample that is adequate for the genotyping proto-
col (e.g. Southern blot), or when the identiﬁcation
aspect of such techniques is redundant or not valid
(e.g. the animal is already identiﬁed or requires a par-
ticular identiﬁcation method other than ear marking,
such as a transponder).
In cases where tail biopsy is used:
1. Mice should preferably be between 14 and 17 days
old;
2. Sample should be no longer than 3mm, except when
the genotyping technique is known to require a large
amount of DNA;
3. A very sharp instrument should be used, with a
clean, precise cutting gesture;
4. In case of bleeding, haemostasis should be enforced;
5. In older animals, the beneﬁts of analgesia or anaes-
thesia should be evaluated.
Distal phalanx biopsy. Distal phalanx biopsy consists
of the removal of the distal phalanx of a newborn
animal, that is then used as a source of DNA. This
method also provides a means of identiﬁcation, and is
described in detail in the literature11–13 and in the
report of the FELASA Identiﬁcation Working Group.
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A similar, non-reﬁned method generally known as
‘toe clipping’ has been largely used in the past, regard-
less of the extent of the biopsy or the age of the animal.
Owing to its mutilating aspect, that method was grad-
ually set aside and is now discouraged or even pro-
hibited in several European countries and institutions.
In our survey, 17 of the 72 scientists reported Animal
Ethics Committee restrictions regarding toe clipping at
their sites of research, other than age-related.
Recent studies3,12–14 have shown that the reﬁned
distal phalanx biopsy of newborns, if properly per-
formed, does not seem to aﬀect mice more than tail
or ear biopsy, neither in the short nor the long
term.12,13 Conversely, tail biopsy has been shown to
aﬀect mice, at least in the short term.10,15
Although the technique is possible earlier, postnatal
day (PND) 7 seems to be the preferred age for distal
phalanx biopsy. At this age, toes are already well sepa-
rated and easy to access,4,12,13 the ossiﬁcation process is
not yet completed,11 and the animals have reduced
movements, which facilitates the accurate biopsy.
There are national and institutional guidelines pointing
out other ages as the limit, such as PND 12.16 However,
we were unable to ﬁnd scientiﬁc grounds for those.
With many studies requiring the genotyping of new-
borns and early genotyping becoming a growing trend, it
is important to re-evaluate the sampling options avail-
able. At very early ages, ear sampling is not possible and
tail biopsy requires concurrent marking techniques. In
the light of current knowledge, distal phalanx biopsy
(reﬁned version) is, therefore, the method of choice to
genotype newborns because it provides both identiﬁca-
tion and a source of good quality DNA on a sole inter-
vention with minimum disturbance of the animals.
Accordingly, we recommend this method with the
following safeguards:
1. At the time of the biopsy, the animals should be
approximately seven days old;
2. Only the most distal phalanx of only one toe per paw
should be removed;
3. No further biopsies should be performed.
We would like to take this opportunity to advocate
early, pre-weaning genotyping. This approach has
many advantages: the animals are easier to handle;
some tissue samples yield more DNA as they are less
ossiﬁed; and genotyping results are available before the
weaning date, allowing for the better planning of
experiments and management of the colonies. As an
extra beneﬁt, housing costs decrease as surplus animals
can be managed before weaning time.
Blood. Blood can be used to extract DNA for genotyp-
ing, although it may present a few technical problems.17
It may also be a convenient method for genotype deter-
mination by using ﬂow cytometry or microscopy-based
techniques.18 In eﬀect, 13% of the researchers who
responded to our survey had used blood to determine
the genotype (Table 1). However, blood sampling does
not enable mouse identiﬁcation. Hence, it can only be
considered as a reﬁnement in terms of sampling for
genotyping in animals already identiﬁed, identiﬁed
with non-invasive methods, or requiring an identiﬁca-
tion method that does not provide a DNA sample (e.g.
transponders).
When this method is chosen, the amount of blood
collected should respect the recommended volumes,
and the collection technique should be the least invasive
that is still appropriate for the required volume and
genotyping method.19
Hair follicles. Hair follicles plucked from the animal
can be used as a source of DNA for genotype identiﬁ-
cation. This technique would reduce the discomfort
associated with the more invasive sampling tech-
niques.3,20 Unfortunately, its throughput is low and
there is a high risk of cross-contamination between
samples of diﬀerent animals.3,20 Moreover, it does not
provide a means of identifying the animals.
Owing to the above constraints, the technique is not
appropriate for routine genotyping of large animal
colonies. However, it can be considered for the follow-
ing cases:
1. Low numbers of animals already identiﬁed, requir-
ing an identiﬁcation method that is not a sampling
method (e.g. transponder) or that can be identiﬁed
through a non-invasive method;
2. Older animals already identiﬁed, requiring an iden-
tiﬁcation method that is not a sampling method (e.g.
transponder) or that can be identiﬁed through a non-
invasive method;
3. Re-sampling for conﬁrmatory testing;
4. Colonies for which an invasive method can pose a
threat (e.g. bleeding disorders).
Based on our survey, less than 1% of the scientists use
hair follicle DNA for mouse identiﬁcation (Table 1).
Colonic and rectal cells. Colonic and rectal cells, col-
lected either by means of a rectal swab or scrape3,21 or
from faecal pellets22–24 can be used as a DNA source
for genotyping. While we would not think of rectal
swabs or scrapes as non-invasive, the collection of
faecal pellets could be a method to consider. Owing
to possible DNA degradation, faecal pellets are to be
obtained freshly,24 or at the latest within 24 h.22 The
faeces need to be individually collected and more
than one faecal pellet per animal is normally required.
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For the above reasons, this method is not practical
when sampling large numbers of animals. In addition,
like hair plucking, the method does not provide a
means for identiﬁcation. Stool sampling may however
be considered in the same situations described for hair
sampling. None of those responding to our query
reported using this method for genotyping.
Cells from the oral mucosa. To obtain oral cells for
DNA sampling, the oral cavity may be scraped25 or
swabbed.26 Alternatively, the oral cavity can be ﬂushed
with a small amount of sterile water, although only a
small amount of cells is retrieved by this technique from
weanling mice.27 This method is widely used for human
DNA collection, as it is virtually non-invasive in
humans. However, there are reports of mice biting
their tongues during the process, and the samples are
often tinted by blood.3 Thus, the size and design of the
collection tools should be carefully considered to keep
the method non-invasive when applied in small rodents.
Although this method could be considered useful for
large colonies due to higher throughput and lower risk
of contaminations when compared with the previous
two methods, the expected low amount of DNA
obtained is a limitation. Furthermore, the method
also does not provide a means of identifying the ani-
mals. For this reason, we suggest that it should also be
reserved for the situations listed for hair follicles and
rectal cells.
None of the survey inquirers reported using this
method.
Summary of sampling recommendations
In conclusion, when considering sampling for genotyp-
ing, we recommend the following:
. Work quietly and be gentle in order to minimize the
stress associated with handling and restraint.
. Whenever possible, use a methodology that simul-
taneously identiﬁes the animals and yields tissue for
genotyping.
. Work carefully to avoid the need for repeating the
procedures: identify the animals in a reliable way;
collect the samples cautiously, and avoid cross-
contamination.
. Whenever possible, opt for early genotyping.
. Collect the minimum amount of tissue that can still
produce enough DNA for the selected genotyping
method.
. Store and ship samples properly, to avoid DNA deg-
radation. Consider extracting immediately and stor-
ing and/or shipping puriﬁed DNA instead of tissue.
Taking into consideration the age of the animals and
the need to permanently identify them or not, Table 2
summarizes our recommended sampling methods for
the most common situations. However, if the genotyp-
ing method requires a higher amount of DNA, or the
recommended technique is inadequate due to physio-
logical constraints of the model or scientiﬁc aspects of
the project, another sampling method may have to be
considered.
Development of an optimized genotyping
protocol
An optimized genotyping protocol is essential to ensure
fast and reliable mouse identiﬁcation. PCR and
Southern blot-based methods are currently by far the
most commonly used methods. This was conﬁrmed by
our survey, with 92% of the respondents reporting the
use of PCR followed by 10% using quantitative PCR,
9% Southern blot/dot blot and 4% single nucleotide
polymorphism (SNP) detection as routine methods (see
Supplementary information http://lan.sagepub.com/
content/suppl/2013/05/28/0023677212473918.DC1/
LAN473918_Supplementaryd_data.pdf).
Table 2. Recommended methods for the collection of samples for genotyping by polymerase chain reaction.
Sampling of animals
requiring permanent ID
Batch sampling of animals not
needing permanent ID*
Re-sampling, small numbers of
animals not needing permanent ID*
Day 5–Day 7 (Day 7 is preferred) Distal phalanx biopsy Distal phalanx biopsy Not applicable
Day 8–Day 13y Distal phalanx biopsy Distal phalanx biopsy (best)
Tail biopsy (3mm)
Not applicable
Day 14–Day 17 Ear biopsy Ear biopsy (best)
Tail biopsy (3mm)
Hair/faeces/saliva Ear biopsyz
After Day 17 Ear biopsy Ear biopsy Hair/faeces/saliva Ear biopsyz
*Also animals that, for experimental or institutional reasons, require an identification (ID) method that does not provide a sample (e.g.
transponders).
yNo information from the literature for this age interval – use good judgement.
zExcept for animals with previous ear marks that could be compromised by that ear biopsy.
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The advantages of the PCR-based methods are the
speed and the low amount of DNA needed, which trans-
late into a low amount of tissue required for sampling.
Only 1–2 ng ofDNAare needed for PCR,while Southern
blot analysis requires microgram quantities ofDNA.We
provide below a few considerations for successful PCR
and Southern-based genotyping of GM rodents.
DNA purification
ProperDNApuriﬁcation is a critical step for setting up a
PCR-based method for mouse identiﬁcation, especially
when a new genotyping protocol is established. After
establishment of the method, the use of highly pure gen-
omic DNA is not always necessary. This is also high-
lighted in our survey where only 18% of the respondents
reported to the use of commercial kits for DNA puriﬁ-
cation as a routine (see Supplementary informa-
tion http://lan.sagepub.com/content/suppl/2013/05/28/
0023677212473918.DC1/LAN473918_Supplementaryd_
data.pdf).
Currently, there are several well-established meth-
ods available for extracting DNA from tissue biopsies.
According to the experience of this Working Group
and the results of our survey (see Supplementary
information), the two most commonly used methods
for tissue digestion are the use of proteinase K in the
presence or absence of sodium dodecyl sulphate
(SDS), and the use of alkaline lysis (HotSHOT
method28). In addition to these methods, there are
several commercial DNA extraction kits available
which tend to be easy to work with but are expensive
to use. The survey conﬁrmed that more than 75% of
the respondents use proteinase K digestion for routine
DNA isolation. We suggest three protocols which
should deliver high-quality genomic DNA from
tissue biopsies for PCR genotyping (see
Supplementary information):
As crude tissue extract is typically used, DNA qual-
ity is not routinely analysed while genotyping GM
mouse colonies. Supplementary Table S4 summarizes
the most important DNA isolation protocols, the
most common tissue sample and the respective pro-
cedure(s) for genotyping, i.e. PCR or Southern blot
methods. Independent of the approach used for
tissue collection, it is important to prevent contamin-
ation between the samples by means of proper work-
ing practices (using clean punching devices and
forceps, avoiding contamination by hair, etc.) and to
store samples properly to prevent DNA degradation.
Where possible, it is also advisable to store part of the
DNA to enable a repeat genotyping to be performed
without the need for additional sampling. This is par-
ticularly important if the test is not optimized, or if
problems are anticipated.
Polymerase chain reaction
This is a technique to amplify even a single copy of a
particular DNA sequence, generating millions of
copies. It is by far the most widely used method for
genotyping routinely, a trend reﬂected in the results
of the survey: 92% of the total number of responders
reported using this method.
General considerations. For transgene detection, 150–
800 base pair long PCR products are typically used for
eﬃcient ampliﬁcation. In multiplex PCR methods it is
important to amplify fragments with similar lengths,
with a preferred length diﬀerence of 50–100 bp, in
order not to favour ampliﬁcation of the shorter prod-
uct. It is essential to set up a robust mutation-indepen-
dent (control) PCR method for a single-copy gene
expected to be present in any mouse strain. This is
used as an internal control for successful DNA extrac-
tion, and to detect putative contaminants that interfere
with DNA ampliﬁcation. With the control genes, a
product is added that should always be present, thus
preventing false-negative results (Figure 1a and b).
Examples of such genes and primer pairs which have
been successfully used are provided in Table 3.
For the genotyping of mutant mice produced with
homologous recombination (such as knock-out and
knock-in mice), typically three primers are used in
PCR (see Figure 1c). In this case, the primers have to
be designed so that the ﬁrst two (forward and reverse)
amplify a gene-speciﬁc region and the third primer
(reverse) is speciﬁc for the selection cassette. In the
normal situation, gene-speciﬁc primers are not able to
amplify a product in the targeted locus (fragment is too
long) and therefore amplify only the wild-type allele.
Also, in this PCR strategy, products should have a dif-
ference in length of about 50–100 bp.
In the maintenance of large animal colonies, it is
important that the PCR conditions are optimized in
such a way that several genotyping PCRs can be per-
formed simultaneously with the same programme. A
detailed protocol for successful genotyping as well as
a troubleshooting guide for PCR are provided as Sup-
plementary document A (please see http://lan.sagepub.
com/content/suppl/2013/05/28/0023677212473918.DC1/
LAN473918_Supplementaryd_data.pdf).
Southern blot analysis
Large amounts of DNA (7–15 mg) of high purity, suit-
able for restriction enzyme cleavage, are needed for
each digest. The resulting DNA fragments are sepa-
rated by electrophoresis, transferred to membranes,
and the transgenic product is visualized after hybridiza-
tion with a speciﬁc labelled probe. The technique takes
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at least three days to complete and can be performed
using non-radioactive labelling.
Southern blot requires more DNA and more tissue,
but it is a required method in some instances. In the
case that transgenics are generated by pronuclear injec-
tion of DNA, as it is the case for many lines carrying
the Cre-expressing transgene, Southern blot is a power-
ful tool for determining the properties of transgene
integration. It can be used: (1) to discriminate between
lines when diﬀerent integration sites occur in each line;
(2) to determine the number of sites of integration; (3)
to determine the transgenic copy number; (4) to verify
the integrity of the transgene and the orientation of the
tandem repeats; and (5) to detect homozygous individ-
uals. Southern blot can also give information of the
locus structure at the integration site and the overall
integrity of the recombined transgene.
Thus, Southern blot is a useful technique to be used
for the characterization of founders of a new transgenic
line. When mutants are generated by gene targeting
strategies, Southern blot is the gold standard for the
identiﬁcation of homologous recombination events in
embryonic stem (ES) cells. In this case it is conceivable
that, after obtaining germline competent chimeric ani-
mals upon injection of targeted ES cells into blasto-
cysts, the mutations in the F1 generation are ﬁrst
tested by PCR, and upon expansion of the colony,
only a representative number of animals is tested by
Southern blotting, avoiding unnecessary collection of
large tail biopsies.
Other genotyping methods
Quantitative realtime PCR. Realtime PCR allows the
accumulation of the ampliﬁed product to be detected
and measured as the reaction progresses. For the detec-
tion of PCR products, a ﬂuorescent molecule is
included in the reaction. This ﬂuorescent molecule
(DNA-binding dyes as SYBR Green or ﬂuorescently
labelled sequence-speciﬁc primers or probes as
TaqMan) reports an increase in the amount of DNA
with a proportional increase in the ﬂuorescent signal,
measuring the amount of ampliﬁed product in realtime.
In realtime PCR, the amount of ampliﬁcation prod-
uct is determined after each cycle, enabling a much
more accurate quantiﬁcation. It has been used for
Figure 1. Use of control genes in polymerase chain reaction.
Table 3. Selection of genes and primers that can be used
as internal controls.
IL-6; interleukin-6 gene
IL-6 For 50-TTC-CAT-CCA-GTT-GCC-TTC-TTG-G-30
IL-6 Rev 50-TTC-TCA-TTT-CCA-CGA-TTT-CCC-AG-30
PCR product 170 bp
Immunoglobulin heavy chain-joining region
Igh-j For 50-TGT-CCA-GGG-TCT-ATC-GGA-CT-30
Igh-j Rev 50-GTT-TTT-CCT-CTG-TAC-CCG-AC-30
PCR product 290 bp
B1 receptor gene; bradykinin receptor, beta 1
B1 For 50-CTC-AGG-GAG-GCC-AGG-ATG-TG-30
B1 Rev 50-TCA-GCG-GGG-TCA-TCA-AGG-CC-30
PCR product 340 bp
VAX 1; ventral anterior homeobox gene
VAX 1 For 50-CGT-AAT-CAA-TTG-CAA-CAG-CGA-G-30
VAX 1 Rev 50-AGA-AGG-AGG-GTG-GGA-AAA-GAA-G-30
PCR product 400 bp
Grem 1; Gremlin 1 gene
Grem 1 For 50-ATG-AAT-CGC-ACC-GCA-TAC-ACT-G-30
Grem 1 Rev 50-TCC-AAG-TCG-ATG-GAT-ATG-CAA-CG-30
PCR product 500 bp
Rb1; Retinoblastoma gene
Rb1 For 50-GGC-GTG-TGC-CAT-CAA-TG-30
Rb1 Rev 50-AAC-TCA-AGG-GAG-ACC-TG-30
PCR product 650 bp
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genotyping,29–31 for copy number detection of a trans-
gene,32 and for determination of zygosity.33 However,
for the latter purpose it should be used with caution as
the method is not very reliable with high copy number
of the transgene of interest. Realtime PCR also pro-
vides an accurate and sensitive method to determine
the ultimate level of the Cre-speciﬁc gene disruption
in conditional mutants with the Cre-loxP system.34
Genome-wide genotyping. Genome-wide genotyping
enables scanning of the whole genome using poly-
morphic genetic markers for the identiﬁcation of gen-
etic diﬀerences between inbred or GM mice. Because
genome-wide genotyping requires high-quality genomic
DNA and adequate DNA quantity, genomic DNA is
usually prepared from tail biopsies using a proteinase
K/SDS lysis buﬀer method followed by a phenol–
chloroform extraction and isopropanol precipitation.
Subsequently, the genetic polymorphisms of test and
control samples are ampliﬁed by PCR and ran on agar-
ose gels or genetic analysers. The whole genome is
scanned with high-density polymorphic markers, such
as simple sequence length polymorphisms (SSLPs) and
SNPs. We recommend using at least 2–3 genotyping
markers, about 30 cM in between each other, to
assess the identity of the chromosomes.
SSLPs, also known as microsatellite markers, are
serial di-, tri-, tetra- or penta-nucleotide repeats, where
the number of repeat units varies among the diﬀerent
inbred strains. They are easily ampliﬁed by PCR using
primers derived from unique sequences ﬂanking the
repeat units, and the length variance (>4 bp) can be
detected on 4% agarose gels. Usually the PCR product
size of SSLP markers ranges from 80 to 250 bp. A dense
genetic map of the mouse with numerous SSLPs that
distinguish diﬀerent inbred strains has been estab-
lished35–37 which is freely accessible through various
websites (Supplementary Table S5; please see http://lan.
sagepub.com/content/suppl/2013/05/28/0023677212473
918.DC1/LAN473918_Supplementaryd_data.pdf) so
that everymolecular biology laboratory can easily estab-
lish its customized panel of SSLPs. Even though SSLP
genotyping is easy and cost-eﬀective, genome-wide gen-
otyping has been further upgraded by the use of SNPs.38
SNPs are single base pair mutations that occur at a
speciﬁc site in the DNA sequence and are the most
common type of genetic variation among inbred
strains. In addition, SNP is the genotyping method of
choice for screening point mutations induced with the
alkylating agent N-ethyl-N-nitrosourea (ENU).39,40 A
plethora of SNP genotyping platforms is currently
available.41 High-throughput technologies genotype
thousands of SNPs simultaneously, including
Aﬀymetrix GeneChip arrays,42 and Illumina
BeadArray technology.43 Both platforms use the same
basic principle of hybridization of genomic DNA frag-
ments to a ﬁxed probe. These microarray technologies
require 250–750 ng of genomic DNA per sample and
only one sample is simultaneously tested for all markers
per assay. Such methods oﬀer a dense scan of the
mouse genome with multiplex SNP genotyping and
have mainly application in genetic mapping screens
but are not considered cost-eﬀective for genotyping a
large panel of mice. Other customized methods for SNP
genotyping, such as Pyrosequencing,44,45 Applied
Biosystems TaqMan approach,46 and Sequenom
MALDI-TOF mass spec47 are readily applied to a
large number of samples, with relatively low running
costs. Since SNP genotyping requires expensive equip-
ments, reagents, experienced personnel, and signiﬁcant
analysis capabilities, it is usually oﬀered as a service by
institutional core facilities (Supplementary Table S5).
Applications of the genome-wide
genotyping methods
Until recently, genome-wide genotyping was exclusively
applied on genetic mapping for the identiﬁcation of the
causal mutation that was responsible for the observed
phenotype. During the last decade, a forward genetics or
phenotype-driven approach (phenotype to gene) was
established in various research centres worldwide
through genome-wide random ENU mutagenesis. This
approach involves screening of thousands of mutagen-
ized mice for mutant phenotypes and subsequent iden-
tiﬁcation of the mutated gene. With the advances in
genome sequencing and the discovery of thousands of
polymorphisms in the mouse genome, the process of
genetic mapping is now much more eﬃcient and signiﬁ-
cantly less time-consuming than a decade ago.
Genome-wide genotyping has also important appli-
cations in the evaluation of the genetic purity and con-
tamination of any mouse genetic background.38 Mutant
lines maintained on an inbred background should be
monitored regularly for evidence of genetic contamin-
ation due to accidental mismating. A genetic quality
monitoring of breeders with approximately 50
genome-wide polymorphic markers oﬀers detection of
massive genetic contamination. However, subtle
changes of the genetic background could be detected
only by a dense scan of the genome with SNPs spreading
all over the genome that are available from diﬀerent
providers (i.e. Aﬀymetrix [www.aﬀmetrix.com],
Illumina [www.illumina.com]). Ultimately the next gen-
eration sequencing allows a complete overview of the
mouse genome of interest and to compare with the ori-
ginal inbred genetic background (http://www.sanger.
ac.uk/resources/mouse/genomes/) A successful genetic
quality control monitoring system is essential for the
maintenance of well-established strain characteristics
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and the reproducibility of experimental data between
diﬀerent groups over time, taking advantages of the
whole genome genotyping techniques described
previously.
Moreover, genome-wide genotyping accelerates dra-
matically the development of congenic strains which are
mutant lines repeatedly backcrossed to an inbred strain.
In this genome-based strategy, named speed congenics,
oﬀspring are genotyped with a genome-wide panel of
genetic markers, and animals with optimal genotype
(those that have retained the mutation and the largest
proportion of recipient background) are selected for the
next breeding step. The optimal breeding strategy
appears to be a 10 cM genome scan of 20–50 males
per backcross generation, which requires approxi-
mately 150 markers per mouse. The advantage of this
approach is the fact that it minimizes the number of
backcrosses required to establish a quality congenic
mouse strain as early as with the ﬁfth backcross gener-
ation48,49 instead of the 10 generations that are needed
if a traditional breeding scheme is followed. Speed con-
genics provides a fast, reliable and cost-eﬀective way
for backcrossing as it reduces by half the time that is
required for the backcrossing of mutant lines, i.e. from
3 to 1.5 years and minimizes the animals that are
needed for backcrossing.
Relevant information for mutated
rodent strains
Most mutants have been generated on a hybrid genetic
background, and it is well known how important the
contribution of the genetic background is to the pheno-
type of a given mutation. Thus, it is essential to keep
adequate records of detailed information on the type of
mutation, methods for genotype identiﬁcation, genetic
background, etc. for all GM mouse strains generated,
and to pass this information together with the mouse
strain to any user and collaborator. An example of such
a data sheet is included as a Supplementary document
B (please see http://lan.sagepub.com/content/suppl/
2013/05/28/0023677212473918.DC1/LAN473918_
Supplementaryd_data.pdf).
Strain identification and type of mutation
Every mutant strain must have a name providing precise
information on the aﬀected gene, the type of mutation,
the parental inbred strain(s) and the code for the labora-
tory where this mutant originates from, which can be
requested from the Institute for Laboratory Animal
Research (ILAR) (Supplementary Table S5).
Nomenclature rules are set by the International
Committee on Standardized Genetic Nomenclature for
Mice and the Rat Genome and Nomenclature
Committee.1 This nomenclature needs to be used in
order to provide unquestionable information about the
type of mutation introduced (Supplementary Table S5).
For any transgene, a schematic presentation describ-
ing in detail the transgene structure used is essential,
including precise information about the gene regulatory
region and the protein coding regions used. For trans-
genic mice, the insertion site is not typically analysed.
However, if known, the ﬂanking sequences of the inte-
gration site should be given.
In case of a gene trap, the genomic locus of the inser-
tion should be provided together with the description of
the targeted locus. This information is available from
the ES cell providers, such as the International Gene
Trap Consortium (Supplementary Table S5). If avail-
able, it is also essential to provide the information
about the insertion site of the gene trap.
For a targeted insertion, a detailed description by
one nucleotide resolution of the targeted locus, includ-
ing positions of exons, introns, possible sites for loxP-
and Frt-sequences, probes and restriction enzyme sites
used for conﬁrming the targeted allele by Southern
blotting, and PCR primers used for routine genotyping
of the targeted locus should be provided, and prefer-
ably indicated also in a schematic drawing.
In general, it is preferable to attach the same infor-
mation electronically in order to facilitate the analysis
of the modiﬁed locus. If available, the original publi-
cation where the mouse model was described for the
ﬁrst time should also be included. Emphasis should
also be given to report the site and type of a putative
antibiotic selection gene and/or the reporter gene
inserted into the locus. As an example, a schematic
presentation of a hypothetical, multipurpose allele is
presented in Figure 2.
Identification of the genotype
For eﬃcient colony maintenance, and to promote sci-
entiﬁc collaboration concerning the various mouse
strains, protocols developed for the genotyping of
rodents should be simple, easy and as robust as pos-
sible. Moreover, these demands should be met by a
method causing minimal stress to the animals.
Figure 2. Example of a multipurpose gene knock-in.
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Once selected, the most appropriate genotyping proto-
col should be recorded along with the strain informa-
tion, so that it could be reproduced without problems.
As mentioned previously, routine genotyping of
mutated mouse strains are preferably performed by
PCR. PCR would allow the distinction of wild-type,
heterozygous and homozygous animals. However, in
transgenic rodents this is not typically possible, due to
the unknown integration site. In those cases, two inde-
pendent primer pairs are designed to amplify a region
with similar size: one speciﬁc for the transgene and
another unrelated pair of primers are designed to dem-
onstrate the proper amount and quality of the DNA in
the specimen. This information should be adequately
recorded and provided.
Equally important is the use of a reliable animal
identiﬁcation system, as no genotype information is
valid without an unquestionable way to link it to an
individual at any time and location within no matter
how large animal facilities. It is, therefore, of the
utmost importance that, not only are the mice well
identiﬁed, but also the identiﬁcation code and corres-
pondent genotype are recorded and conveyed when
transferring the animals to a diﬀerent location.
Sometimes it is possible to identify the mutants by
the phenotype. However, discriminating the mutant
and wild-type littermates by the macroscopic appear-
ance only is not always advisable. This is due to the fact
that the phenotypic features might vary between the
individuals, especially between generations and in the
diﬀerent genetic backgrounds.
Genetic background
The original genetic background (donor strain) onto
which the mutation was originally introduced – e.g.
embryo donors for the transgenic mouse production
and the ES cell line used for homologous recombin-
ation or for the production of the gene trap clone –
should be described. Since phenotypic changes in the
mutant rodent also depend on the genetic background,
it is essential to provide a summary of the breeding
history of the mouse model. International laboratory
codes should be kept, as well as the terms Fxx, to indi-
cate the number (xx) of intercrosses, or Nyy to indicate
the number (yy) of backcross generations from a donor
to a new recipient background.1 As importantly, the
gender of the carrier should be indicated as deﬁned
by the International Committee on Standardized
Genetic Nomenclature.
Typically, backcrossing a mutation generated in a
donor background for up to 10 generations into a
new recipient background is considered necessary to
produce a homogenous inbred mouse strain.
However, it should be remembered that the genomic
regions close to the genotyped mutation do not typic-
ally undergo homologous recombination; those regions
are, thus, not backcrossed, containing alleles of the
donor background for genes located at the vicinity of
the mutation. If additional techniques are used, such as
speed congenics,48 a description of the genetic markers
used and located proximal to the mutation should be
provided. Alternatively, performing a survey of the
genetic background using high-density genetic markers
such as SNP arrays developed by commercial compa-
nies would be recommended.42,43
The user needs to remember that some strains have
particular characteristics (e.g. they are more prone to
certain types of diseases). Thus, when using back-
crossed mutants it is often needed to monitor unex-
pected inﬂuences of the genetic background. These
possible changes should also be recorded along with
the strain information.
Husbandry characteristics
To obtain and provide a short summary of the known
phenotypic changes aﬀecting the health and general ﬁt-
ness – and therefore, putatively required to apply for
project approval by animal ethical committees and to
adequately maintain the strains – is of the utmost rele-
vance. Information on fertility of both genders, and any
special considerations concerning the breeding strategies
to be applied, should be monitored and conveyed.
Similarly, information on the viability and fertility of
both heterozygous and homozygous mutants should
be recorded and provided for appropriate breeding
strategy, housing, handling and maintenance of the
mouse line.
Data on the history of the microbiological status of
the rodent strain are of key importance for a smooth
colony transfer between laboratories, and to recognize
any health problems that might not be linked to the
mutation itself. Indeed, even the bacterial gut ﬂora
could interfere with the mutation introduced (in par-
ticular for genes controlling metabolism or immunity)
and impact the health or the response of the mutant.
Concluding remarks
The increasing number and complexity of GM rodent
strains has determined a corresponding increase in the
number and complexity of the procedures required for
their successful generation, maintenance and use. It has
also, fortuitously, resulted in increasing scientiﬁc stu-
dies aimed at reﬁning these procedures in terms of
eﬀectiveness and of animal welfare. Unfortunately,
many scientists are still making use of ‘traditional’ gen-
otyping-associated procedures, even if these are not the
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most appropriate in terms of animal welfare or even of
success.
With the present guidelines, we aim to further imple-
ment the concept of the 3Rs on genotyping-associated
procedures, reﬁning and harmonizing them in the light
of the latest scientiﬁc ﬁndings, and according to the
current scenario of animal research.
We believe that the proposed recommendations will
lead to better animal welfare while improving scientiﬁc
results and saving time and resources.
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